Acumen pharmaceuticals to participate in upcoming investor and scientific conferences

Charlottesville, va. and carmel, ind., july 26, 2022 (globe newswire) -- acumen pharmaceuticals, inc. (nasdaq: abos), a clinical stage biopharmaceutical company focused on the development of novel targeted therapeutics for alzheimer's disease (ad), today announced that the company will participate in the following upcoming conferences:
ABOS Ratings Summary
ABOS Quant Ranking